Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study

NCT03233178 · clinicaltrials.gov ↗

COMPLETED

Status

4000

Enrollment

OTHER

Sponsor class

Conditions

T2DM (Type 2 Diabetes Mellitus)
Fatty Liver
NAFLD

Interventions

OTHER: Non-interventional

Sponsor

LMC Diabetes & Endocrinology Ltd.